Literature DB >> 34263716

Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.

D I Krijbolder1, M Verstappen1, F Wouters1, L R Lard2, Pdm de Buck3, J J Veris-van Dieren4, J L Bloem5, M Reijnierse5, Ahm van der Helm-van Mil1,6.   

Abstract

OBJECTIVE: Magnetic resonance imaging (MRI) of small joints sensitively detects inflammation. This inflammation, and tenosynovitis in particular, has been shown to predict rheumatoid arthritis (RA) development in arthralgia patients. These data have predominantly been acquired on 1.0-1.5 T MRI. However, 3.0 T is now commonly used in practice. Evidence on the comparability of these field strengths is scarce and has never included subtle inflammation in arthralgia patients or tenosynovitis. Therefore, we assessed the comparability of 1.5 T and 3.0 T in detecting subclinical inflammation in arthralgia patients.
METHOD: A total of 2968 locations (joints, bones, tendon sheaths) in the hands and forefeet of 28 patients with small-joint arthralgia, at risk for RA, were imaged on both 1.5 and 3.0 T MRI. Two blinded readers independently scored erosions, osteitis, synovitis, and tenosynovitis, in line with the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS). Features were summed into inflammation (osteitis, synovitis, tenosynovitis) and RAMRIS (inflammation and erosions). Agreement was assessed with intraclass correlation coefficients (ICCs) for continuous scores and after dichotomization into presence or absence of inflammation, on patient and location levels.
RESULTS: Interreader ICCs were excellent (> 0.90). Comparing 1.5 and 3.0 T revealed an ICC of 0.90 for inflammation and RAMRIS. ICCs for individual inflammation features were: tenosynovitis 0.87 (95% confidence interval 0.74-0.94), synovitis 0.65 (0.24-0.84), and osteitis 0.96 (0.91-0.98). Agreement was 83% for inflammation and 89% for RAMRIS. Analyses on the location level showed similar results.
CONCLUSION: Agreement on subclinical inflammation between 1.5 T and 3.0 T was excellent. Although synovitis scores were slightly different, synovitis often occurs simultaneously with other inflammatory signs, suggesting that scientific results on the predictive value of MRI-detected inflammation for RA, obtained on 1.5 T MRI, can be generalized to 3.0 T MRI.

Entities:  

Mesh:

Year:  2021        PMID: 34263716      PMCID: PMC7612912          DOI: 10.1080/03009742.2021.1935313

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.057


  21 in total

1.  Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents.

Authors:  P A Rinck; R N Muller
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

2.  A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis.

Authors:  Paul Bird; Bo Ejbjerg; Marissa Lassere; Mikkel Østergaard; Fiona McQueen; Charles Peterfy; Espen Haavardsholm; Philip O'Connor; Harry Genant; John Edmonds; Paul Emery; Philip G Conaghan
Journal:  J Rheumatol       Date:  2007-04       Impact factor: 4.666

3.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

4.  The Course of Bone Marrow Edema in Early Undifferentiated Arthritis and Rheumatoid Arthritis: A Longitudinal Magnetic Resonance Imaging Study at Bone Level.

Authors:  Wouter P Nieuwenhuis; Hanna W van Steenbergen; Wouter Stomp; Theo Stijnen; Tom W J Huizinga; Johan L Bloem; Désirée van der Heijde; Monique Reijnierse; Annette H M van der Helm-van Mil
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

5.  Influence of field strength, coil type and image resolution on assessment of synovitis by unenhanced MRI--a comparison with contrast-enhanced MRI.

Authors:  Iris Eshed; Simon Krabbe; Mikkel Østergaard; Pernille Bøyesen; Jakob M Møller; Flemming Therkildsen; Ole Rintek Madsen; Mette Axelsen; Susanne Juhl Pedersen
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

6.  Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.

Authors:  Hanna W van Steenbergen; Lukas Mangnus; Monique Reijnierse; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2015-11-27       Impact factor: 19.103

7.  Comparison of 1.0-T extremity MR and 1.5-T conventional high-field-Strength MR in patients with rheumatoid arthritis.

Authors:  Ali M Naraghi; Lawrence M White; Chirag Patel; George Tomlinson; Edward C Keystone
Journal:  Radiology       Date:  2009-04-20       Impact factor: 11.105

8.  Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study.

Authors:  Makoto Sasaki; Eri Shibata; Yoshiyuki Kanbara; Shigeru Ehara
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

9.  High-resolution MRI of the wrist and finger joints in patients with rheumatoid arthritis: comparison of 1.5 Tesla and 3.0 Tesla.

Authors:  Gero Wieners; Jacqueline Detert; Florian Streitparth; Maciej Pech; Frank Fischbach; Gerd Burmester; Jens Ricke; Marina Backhaus; Harald Bruhn
Journal:  Eur Radiol       Date:  2007-01-12       Impact factor: 7.034

10.  Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis.

Authors:  Cleo Rogier; Silvia Hayer; Annette van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2019-12-19       Impact factor: 19.103

View more
  1 in total

Review 1.  The value of MRI for detecting subclinical joint inflammation in clinically suspect arthralgia.

Authors:  Anna M P Boeren; Edwin H G Oei; Annette H M van der Helm-van Mil
Journal:  RMD Open       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.